News | June 04, 2007

GE Sets PET Motion Free at SNM

June 5, 2007 - GE Healthcare introduced at SNM a new version of the company’s Discovery Dimension designed to help clinicians advance towards the goal of motion free PET/CT imaging, addressing the PET and CT imaging mismatches related to respiratory and cardiac motion. These include motion correction techniques that effectively improve clinical results and minimize blur caused by motion.
Discovery Dimension provides high definition PET image processing, patient motion management and clinical productivity features that together address motion, which is one of the most significant factors in lesion characterization that degrade PET/CT image quality.
“Our use of PET and CT 4-D respiratory motion imaging provides improved lesion detectability, quantitative accuracy and valuable information for radiation treatment planning,” said Professor Ferruccio Fazio, Director of Hospital San Raffaele (HSR) PET and Radiotherapy Center Milan, Italy. “All are significant in the comparative assessment of lesions in follow up studies before and after therapy.”


Related Content

News | PET Imaging

Nov. 17, 2025 — GE HealthCare has announced that Cardiovascular Associates of America (CVAUSA) plans to broaden its ...

Home November 17, 2025
Home
News | PET Imaging

Sept. 18, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology ...

Home September 22, 2025
Home
News | PET Imaging

Sept. 8, 2025 — GE HealthCare recently announced a Distribution and Services Agreement (DSA) with CardioNavix, a part of ...

Home September 08, 2025
Home
News | PET Imaging

July 21, 2025 — Long COVID patients with abnormal cardiopulmonary PET/MR findings may be more likely to develop heart ...

Home July 22, 2025
Home
News | PET Imaging

Feb. 25, 2025— GE HealthCare has delivered the first patient doses of Flyrcado (flurpiridaz F 18) injection, a unit dose ...

Home March 03, 2025
Home
News | PET Imaging

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Home June 18, 2024
Home
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Home June 14, 2024
Home
News | PET Imaging

October 5, 2023 — Jubilant DraxImage Inc., a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an ...

Home October 05, 2023
Home
News | PET Imaging

December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass ...

Home December 01, 2022
Home
News | PET Imaging

September 14, 2022 — GE Healthcare and Lantheus Holdings Inc have announced that the recent Phase III clinical trial of ...

Home September 14, 2022
Home
Subscribe Now